...
首页> 外文期刊>Journal of pharmacological sciences. >Epibatidine Induces Long-Term Potentiation (LTP) via Activation of α4β2 Nicotinic Acetylcholine Receptors (nAChRs) In Vivo in the Intact Mouse Dentate Gyrus: Both α7 and α4β2 nAChRs Essential to Nicotinic LTP
【24h】

Epibatidine Induces Long-Term Potentiation (LTP) via Activation of α4β2 Nicotinic Acetylcholine Receptors (nAChRs) In Vivo in the Intact Mouse Dentate Gyrus: Both α7 and α4β2 nAChRs Essential to Nicotinic LTP

机译:Epibatidine通过在完整小鼠齿状回中体内激活α4β2烟碱乙酰胆碱受体(nAChRs)诱导长期增强(LTP):烟碱LTP必不可少的α7和α4β2nAChRs。

获取原文
           

摘要

References(40) Cited-By(29) Activation of nicotinic acetylcholine receptors (nAChRs) induces nocotinic long-term potentiation (LTPn) in vivo in the mouse dentate gyrus. We have found that α4β2 nAChRs activated by epibatidine induce LTPn, the full size of which requires the involvement of α4β2 and α7 nAChRs, in the intact mouse dentate gyrus using extracellular recording techniques. Intraperitoneal application of epibatidine, a potent α4β2 nAChR agonist, at 0.3 – 3.0 μg/kg induced a long-lasting increase similar to LTPn induced by choline, a selective α7 nAChR agonist, and at 10 μg/kg caused a transient increase followed by a depression. The LTPn induced by epibatidine at 3.0 μg/kg or choline at 30 mg/kg was significantly suppressed by pre-treatment but not post-treatment with mecamylamine (0.5 mg/kg, i.p.), a non-selective neuronal nicotinic antagonist. Post-application of nicotine at 3.0 mg/kg enhanced epibatidine-induced LTPn to the same level of nicotine-induced LTPn, but post-application of epibatidine had no effect on nicotine-induced LTPn. Epibatidine-induced LTPn was additionally increased by post-application of choline, and vice versa, reaching the same level of nicotine-induced LTPn. The present study revealed that epibatidine induced the LTPn via α4β2 nAChRs and that both α7 and α4β2 nAChRs were essential for full-sized LTPn, suggesting that both nAChRs play an important role in synaptic plasticity.
机译:参考文献(40)引用(29)烟碱型乙酰胆碱受体(nAChRs)的激活在小鼠齿状回体内体内诱导了Nocotinic长期增强(LTPn)。我们已经发现,使用细胞外记录技术在完整的小鼠齿状回中,被Epibatidine激活的α4β2nAChRs诱导LTPn的完整大小需要α4β2和α7nAChRs的参与。于0.3 – 3.0μg/ kg腹膜内应用强效的α4β2nAChR激动剂Epibatidine引起持久的增加,类似于选择性的α7nAChR激动剂胆碱引起的LTPn,而在10μg/ kg时引起短暂增加,接着是萧条。依帕替丁3.0μg/ kg或30 mg / kg胆碱诱导的LTPn可以通过美加明胺(0.5 mg / kg,i.p.)的预处理进行显着抑制,而经非选择性神经元烟碱类拮抗剂进行后处理则无法显着抑制。以3.0 mg / kg的尼古丁施用后,将依巴替丁诱导的LTPn增强至与尼古丁诱导的LTPn相同的水平,但施用的依巴替丁对尼古丁诱导的LTPn没有影响。 Epibatidine诱导的LTPn通过胆碱的后施用额外增加,反之亦然,达到相同水平的尼古丁诱导的LTPn。本研究表明,依巴替丁通过α4β2nAChRs诱导LTPn,并且α7和α4β2nAChRs对于全尺寸LTPn都是必不可少的,表明这两种nAChRs在突触可塑性中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号